Kratom News logo
New York 7-OH kratom ban awaiting Governor Hochul's signature, June 2026

New York’s 7-OH kratom ban is now sitting on Governor Kathy Hochul’s desk. In the final hours of the 2026 legislative session, both chambers in Albany unanimously passed legislation that would prohibit the sale of synthetic, concentrated 7-hydroxymitragynine (7-OH) products — the potent isolates often nicknamed “gas-station heroin.” The bill now awaits the Governor’s signature, and if signed it would take effect 90 days later, with manufacturers given additional time to bring products into compliance.

Here is the part that matters for the millions of Americans who use traditional kratom responsibly: this is not a ban on natural-leaf kratom. Like a growing number of 2026 measures, the New York 7-OH bill draws a sharp line between the whole-leaf botanical and the lab-concentrated compound that has alarmed regulators and public-health officials.

NEW YORK 7-OH BILL — BY THE NUMBERS
Unanimous
Passed both the Senate and Assembly
90 days
Until the law would take effect if signed
180 days
Compliance window for existing products

🌿 What the bill actually does

The legislation targets concentrated and synthetic 7-OH — the tablets, gummies, shots and drink mixes that are formulated to contain dramatically more 7-hydroxymitragynine than occurs naturally in the kratom leaf. In an unadulterated kratom leaf, 7-OH is a trace component; mitragynine is the dominant alkaloid. Manufacturers, however, have learned to isolate or semi-synthesize 7-OH and pack it into products at concentrations that behave far more like a classic opioid. That difference in potency is the entire reason lawmakers acted.

New York is not starting from scratch here. In December 2025, Governor Hochul signed two earlier kratom laws — one setting a 21-and-over age requirement for kratom sales, and another requiring full ingredient lists and consumer warning labels on every kratom product sold in the state. The new 7-OH measure builds on that consumer-protection foundation rather than replacing it. New York’s Department of Health has been specifically monitoring 7-OH since June 2025.

New York 7-OH kratom ban targets concentrated products, not natural leaf

🌍 Part of a national pattern, not a one-off

The New York 7-OH kratom ban fits a remarkably consistent 2026 trend: states are increasingly choosing to regulate the concentrated compound while leaving the natural leaf available to adults. That same logic showed up when the American Medical Association urged a 7-OH crackdown that deliberately spared whole-leaf kratom, and again when North Carolina advanced SB 59 to set an age limit rather than impose an outright ban.

Not every state has taken the surgical approach. Several have moved toward broader prohibition — Tennessee’s ban takes effect July 1, 2026, making it the eighth state to prohibit the leaf entirely. The result is a country splitting into two camps: one regulating kratom through Kratom Consumer Protection Act (KCPA)-style frameworks, the other banning it. New York, for now, is firmly in the regulation camp — and its 7-OH bill is arguably the most targeted version of that philosophy yet.

“Restricting the sale of synthetic 7-OH while preserving access to natural leaf is the kind of distinction that consumer advocates have been asking lawmakers to draw for years.”

🧬 Why 7-OH worries regulators

7-hydroxymitragynine is a metabolite of mitragynine and binds to the body’s mu-opioid receptors with considerable strength. When consumed at the trace levels found in brewed or powdered leaf, its effect is modest. But concentrated 7-OH products can produce a much stronger opioid-like effect, and research into their potential for dependence and overdose is ongoing. That is precisely why public-health officials have flagged these isolates as a category that deserves separate, stricter treatment from the traditional botanical.

It is worth being honest about the underlying safety picture. Kratom — even natural leaf — can create tolerance, physical dependence and withdrawal, and people considering it should weigh that real dependence risk. Most serious adverse events historically linked to kratom involved combinations with other substances such as fentanyl, benzodiazepines or alcohol. The constructive takeaway from New York’s approach is that good labeling, age limits and lab-tested supply chains give consumers the information they need to make safer choices, while the 7-OH restriction removes the most pharmacologically aggressive products from gas-station shelves.

📊 What happens next

The bill awaits action from Governor Hochul. Given that she has already signed two kratom-related laws and that this measure passed unanimously with bipartisan support, signature is widely expected — though as of this writing it has not yet been signed. If it becomes law, expect a 90-day runway before enforcement begins, plus a longer compliance window for products already in distribution. For consumers, the practical effect would be that concentrated 7-OH shots and tablets disappear from New York retail, while natural-leaf kratom powder and capsules remain legal for adults 21 and older.

For the broader industry, the New York 7-OH kratom ban would make New York one of the largest markets to formally separate 7-OH from leaf in statute — a precedent that other states weighing similar bills are likely to study closely.

Partner Kratom Stores

The stores below are partner sites of Kratom News and support this publication. These are promotional links — always do your own research and review each vendor’s lab results before buying.

See our full vendor guide: Where to Buy Kratom Online →

❓ Frequently asked questions

Does the New York 7-OH ban outlaw all kratom?

No. The New York 7-OH bill targets concentrated and synthetic 7-hydroxymitragynine products. Natural whole-leaf kratom powder and capsules would remain legal for adults 21 and older under the state’s existing age and labeling laws.

Has Governor Hochul signed the New York 7-OH ban yet?

As of this writing, no. The bill passed both houses unanimously and is awaiting the Governor’s signature. If signed, it would take effect roughly 90 days later, with an additional compliance window for products already in distribution.

What is 7-OH, and why is it treated differently from kratom leaf?

7-OH (7-hydroxymitragynine) is a minor natural component of kratom that becomes a strong opioid-like agonist when concentrated. Manufacturers produce it at far higher levels than occur in the leaf, which is why lawmakers single it out for stricter rules.

When would the New York 7-OH ban take effect?

If Governor Hochul signs it, the law is structured to take effect 90 days after becoming law. Manufacturers of products already in commercial distribution would have an additional period (reported at 180 days) to achieve compliance.

Is kratom safe to use?

Kratom carries a real dependence risk and can cause tolerance and withdrawal, and serious adverse events have often involved mixing it with other substances. This article is news reporting, not medical advice — consult a healthcare professional before using kratom.

Sources

Disclaimer: This article is for news and informational purposes only and is not medical advice. Kratom and 7-OH products can be habit-forming and carry a risk of dependence. Always consult a qualified healthcare provider before using kratom, and review a vendor’s third-party lab results before purchasing.